CN101544644A - 盐酸米安色林的制备方法 - Google Patents
盐酸米安色林的制备方法 Download PDFInfo
- Publication number
- CN101544644A CN101544644A CN200910020782A CN200910020782A CN101544644A CN 101544644 A CN101544644 A CN 101544644A CN 200910020782 A CN200910020782 A CN 200910020782A CN 200910020782 A CN200910020782 A CN 200910020782A CN 101544644 A CN101544644 A CN 101544644A
- Authority
- CN
- China
- Prior art keywords
- midbody
- reactor
- hours
- drop
- mole proportioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004843 mianserin hydrochloride Drugs 0.000 title claims abstract description 16
- YNPFMWCWRVTGKJ-UHFFFAOYSA-N mianserin hydrochloride Chemical compound [H+].[Cl-].C1C2=CC=CC=C2N2CCN(C)CC2C2=CC=CC=C21 YNPFMWCWRVTGKJ-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 12
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019253 formic acid Nutrition 0.000 claims abstract description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 6
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 claims abstract description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- QTQUJRIHTSIVOF-UHFFFAOYSA-N amino(phenyl)methanol Chemical group NC(O)C1=CC=CC=C1 QTQUJRIHTSIVOF-UHFFFAOYSA-N 0.000 claims description 5
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 claims description 5
- 235000017550 sodium carbonate Nutrition 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000019256 formaldehyde Nutrition 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- -1 phenyl aldehyde Chemical class 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 3
- 235000015320 potassium carbonate Nutrition 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000002639 sodium chloride Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims description 2
- 229910001948 sodium oxide Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 abstract 4
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 235000011087 fumaric acid Nutrition 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 2
- 230000001078 anti-cholinergic effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001519 thymoleptic effect Effects 0.000 description 2
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000012549 congenital acardia Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100207824A CN101544644B (zh) | 2009-05-05 | 2009-05-05 | 盐酸米安色林的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100207824A CN101544644B (zh) | 2009-05-05 | 2009-05-05 | 盐酸米安色林的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101544644A true CN101544644A (zh) | 2009-09-30 |
CN101544644B CN101544644B (zh) | 2011-09-28 |
Family
ID=41192039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100207824A Active CN101544644B (zh) | 2009-05-05 | 2009-05-05 | 盐酸米安色林的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101544644B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104888124A (zh) * | 2015-06-17 | 2015-09-09 | 山东仁和堂药业有限公司 | 盐酸米安色林的合成工艺及其检测方法 |
CN105012864A (zh) * | 2015-06-17 | 2015-11-04 | 山东仁和堂药业有限公司 | 盐酸米安色林新晶型及其检测方法和应用 |
CN108191873A (zh) * | 2018-01-08 | 2018-06-22 | 山东省食品药品检验研究院 | 一种盐酸米安色林的纯化方法 |
CN108250203A (zh) * | 2018-03-22 | 2018-07-06 | 仁和堂药业有限公司 | 盐酸米安色林片剂的合成工艺 |
CN108451917A (zh) * | 2018-03-22 | 2018-08-28 | 仁和堂药业有限公司 | 高稳定性米安色林制剂的制备方法 |
CN110256371A (zh) * | 2019-07-09 | 2019-09-20 | 京山瑞生制药有限公司 | 一种新的氟苯尼考关键中间体的制备方法 |
CN117777144A (zh) * | 2023-12-26 | 2024-03-29 | 仁和堂药业有限公司 | 一种盐酸米安色林新晶型ⅱ及其制备方法 |
-
2009
- 2009-05-05 CN CN2009100207824A patent/CN101544644B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104888124A (zh) * | 2015-06-17 | 2015-09-09 | 山东仁和堂药业有限公司 | 盐酸米安色林的合成工艺及其检测方法 |
CN105012864A (zh) * | 2015-06-17 | 2015-11-04 | 山东仁和堂药业有限公司 | 盐酸米安色林新晶型及其检测方法和应用 |
CN108191873A (zh) * | 2018-01-08 | 2018-06-22 | 山东省食品药品检验研究院 | 一种盐酸米安色林的纯化方法 |
CN108250203A (zh) * | 2018-03-22 | 2018-07-06 | 仁和堂药业有限公司 | 盐酸米安色林片剂的合成工艺 |
CN108451917A (zh) * | 2018-03-22 | 2018-08-28 | 仁和堂药业有限公司 | 高稳定性米安色林制剂的制备方法 |
CN110256371A (zh) * | 2019-07-09 | 2019-09-20 | 京山瑞生制药有限公司 | 一种新的氟苯尼考关键中间体的制备方法 |
CN117777144A (zh) * | 2023-12-26 | 2024-03-29 | 仁和堂药业有限公司 | 一种盐酸米安色林新晶型ⅱ及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101544644B (zh) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101544644B (zh) | 盐酸米安色林的制备方法 | |
CN101560183B (zh) | 5-溴-2-甲基吡啶的制备方法 | |
CN102584677A (zh) | 一种格列齐特的制备方法 | |
CN105566138A (zh) | 一种合成西他列汀中间体的方法 | |
CN103420902A (zh) | 一种2-氯-4-碘-5-甲基吡啶的制备方法 | |
CN102295536B (zh) | 一种高含量三甲基氢醌的制备方法 | |
CN102746211A (zh) | 一种取代吲哚-3-甲醛类化合物的制备方法 | |
CN101940951B (zh) | 一种负载型手性催化剂及其应用于催化制备氟西汀中间体 | |
CN102311394B (zh) | 一种5-乙基-5-苯基巴比妥酸的制备方法 | |
CN105198707B (zh) | 4‑联苯甲醇的合成方法 | |
CN103664849B (zh) | 制备2‑(1,6,7,8‑四氢‑2H‑茚并[5,4‑b]呋喃‑8‑亚基乙胺的方法 | |
CN103804232B (zh) | 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用 | |
CN102617454A (zh) | 一种4-吡啶甲醛的制备方法 | |
CN102649742A (zh) | 提高乙醇酸酯选择性的方法 | |
CN101003535A (zh) | α-羟基-α-苯基苯乙酸 8-氮杂双环[3.2.1]-3-庚酯及中间体化合物及其制备方法 | |
CN102964280A (zh) | 一种对甲苯磺酰脲的制备方法 | |
CN102070693A (zh) | 一种7-酮去氧胆酸手性催化氢化生成熊去氧胆酸的方法 | |
CN104193701A (zh) | 一种3-羟甲基四氢呋喃的合成方法 | |
CN103435490A (zh) | 一种2,2,4,4,6,6-六硝基金刚烷的合成方法 | |
CN101481335B (zh) | 卡巴拉汀中间体的制备方法 | |
CN102391075B (zh) | 1-芳基-2,2-二甲基-1,3-丙二醇的制备方法 | |
CN102584609B (zh) | 一种沙美特罗的制备方法 | |
CN101665420B (zh) | 一种制备香兰素的方法 | |
CN101481334A (zh) | 一种适于工业化生产的卡巴拉汀的制备方法 | |
CN103554113B (zh) | 一种盐酸齐帕特罗的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Zhenqiao Inventor after: Ji Benyuan Inventor before: Zhao Zhenqiao |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171019 Address after: 276600 Shandong Province Economic Development Zone Linyi city Junan County Road, Huaihai Road West first Tong Ren Pharmaceutical Co. Ltd. Patentee after: RENHETANG PHARMACEUTICAL CO.,LTD. Address before: 276600 Shandong city of Linyi province Junan County Democratic Road 106, Shandong Tong Ren Pharmaceutical Co. Ltd. Patentee before: SHANDONG RENHETANG PHARMACEUTICAL CO.,LTD. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of mianserin hydrochloride Effective date of registration: 20210629 Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980005474 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220629 Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2021980005474 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of mianserin hydrochloride Effective date of registration: 20220630 Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2022980009655 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230620 Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2022980009655 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of mianserin hydrochloride Effective date of registration: 20230621 Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2023980045254 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2023980045254 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of Mianserin hydrochloride Granted publication date: 20110928 Pledgee: Shandong Linyi Hedong Rural Commercial Bank Co.,Ltd. Pledgor: RENHETANG PHARMACEUTICAL CO.,LTD. Registration number: Y2024980022906 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |